Akoya Biosciences, Inc.

AKYA · NASDAQ
Analyze with AI
3/31/2025
12/31/2024
9/30/2024
6/30/2024
Operating Activities
Net Income-$16-$8-$11-$13
Dep. & Amort.$2$2$2$2
Deferred Tax$0-$0$0$0
Stock-Based Comp.$2$2$2$3
Change in WC$3$1$12-$4
Other Non-Cash$1$1-$14$1
Operating Cash Flow-$7-$3-$9-$11
Investing Activities
PP&E Inv.-$0-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$4-$17-$18-$22
Inv. Sales/Matur.$20$21$31$31
Other Inv. Act.$0$0$0$0
Investing Cash Flow$16$3$13$9
Financing Activities
Debt Repay.-$0-$1-$0-$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$2
Financing Cash Flow-$0-$0-$0-$2
Forex Effect$0$0$0$0
Net Chg. in Cash$9-$1$4-$4
Supplemental Information
Beg. Cash$12$13$10$14
End Cash$21$12$13$10
Free Cash Flow-$7-$4-$10-$11